SUMMARY The influence of ,B blockade on the ability of ST depression, during pre-discharge exercise testing, to predict coronary anatomy and subsequent complications was studied in 300 consecutive post-infarct patients, 125 of whom underwent cardiac catheterisation. At the time of exercise 62 patients were taking a a blocker. The exercise test had a higher sensitivity in predicting multivessel disease in patients who were not taking a blockers than in patients who were (95% v 76%). B Blockade did not, however, influence the ability of the test to identify patients at risk of subsequent cardiac events (sensitivity 84% and 85% respectively).
evidence ofacute myocardial infarction who survived to discharge from our coronary care unit were considered for pre-discharge exercise testing.'°We did not test patients with uncontrolled angina pectoris or cardiac failure, those with other serious cardiac or non-cardiac disease which would limit ability to exercise or affect short term prognosis, and patients who were unwilling to perform an exercise test.
ELECTROCARDIOGRAPHIC CHANGES
A diagnosis ofmyocardial infarction was based on the development of new Q waves or the evolution of ST-T wave changes on the electrocardiogram in association with either a typical history of chest pain persisting for at least 30 minutes or a rise in the concentration of aspartate transaminase or lactic dehydrogenase to twice the upper limit of normal. The site of infarction was determined from the resting electrocardiogram in the following way: in anterior infarction changes were seen in leads Vl-V5, in lateral infarction in leads V6, I, and aVL, and in inferior infarction in leads II, III, and aVF.
All exercise tests were performed on a treadmill according to a modified Naughton's protocol." A 12 lead electrocardiogram, blood pressure, and heart rate were recorded at rest and at one minute intervals throughout the test. After the test, data were recorded every two minutes up to 10 minutes. Some patients had more than one cardiac event during the follow up period. Therefore, the number of patients who suffered one or more cardiac events was noted. As death and reinfarction are the two most important cardiac events the number of patients with these major complications was also noted.
Exercise test results were related to clinical outcome. In this context, ST depression in a patient who experienced at least one subsequent cardiac event indicated a true positive result while ST depression in a patient who did not experience any cardiac event during the follow up indicated a false positive result. A true negative result indicated a patient who had neither ST depression on exercise nor any subsequent cardiac events, while a false negative result indicated a patient who did not have ST depression on exercise but did experience at least one cardiac event on follow up.
STATISTICAL ANALYSIS
Student's t test was used to assess differences between the means ofindependent observations. The x2 test was used to assess differences between proportions. A p value < 0 05 was regarded as statistically significant. Values are given as mean (SD).
Results
Three hundred and fifty patients were considered for exercise testing over an 18 month period. Fifty did not perform a pre-discharge exercise test: 38 because of heart failure, seven because of the presence of other serious medical conditions, three because of Exercise duration 10-4 (3-3) 10-7 (3 2) -0-8 to + 1-4 (mm)
AST, Aspartate aminotransferase; LDH, lactic dehydrogenase. practical difficulties, and two refused to exercise. Of the 300 patients who were exercised 158 had ST segment depression on exercise. The mean age of the exercised patients was 53 years (range 28-65 years).
The male/female ratio was 5-4: 1.
# BLOCKADE At the time of exercise 62 of the 300 patients were already taking a ( blocker; 42 patients had been started on a ( blocker in the early stages of acute myocardial infarction, 13 had been taking P blockers before infarction, and seven had been started on treatment after their infarct because of angina pectoris (four) or hypertension (three). Of the 158 patients with ST depression, 27 were taking a ( blocker at the time of exercise and 131 were not. In those who were being treated with ( blockers and those who were not age, sex, Norris index, enzymatically estimated infarct size, and infarct site were similar (table 1). The two groups exercised for a similar length of time (10-4 (3 3) and 10-7 (3 2) minutes respectively) and had a similar degree of ST depression (2-2 (0-9) and [2] [3] [4] [5] [6] (1 1) mm respectively). Thirty seven per cent ofthose on ( blockers and 45% of those who were not developed angina pectoris on exercise testing (X2 = 1 1; NS). ,B Blockade and post-infarct exercise testing unit. In addition, some patients may be started on a # blocker while in the coronary care unit, either to limit infarct size,"' 14 or for angina pectoris. Stopping such treatment before exercise testing is hazardous, particularly after myocardial infarction, because of the risk of a rebound effect." As a result many patients perform their pre-discharge post-infarct exercise tests while they are taking ,B blockers. Until now the impact of ( blockade on the results of pre-discharge exercise testing had not been studied.
In the current study the sensitivity of pre-discharge exercise testing in detecting multivessel disease was lower in patients taking ( blockers (76%) than in those who were not (95%). Our data seem to be at variance with those of Marcomichelakis et al, who studied patients with suspected coronary disease who had not suffered an infarct before and after the introduction of ( blockade. No STD (n = 26) 3 (1) 478 Murray, Tan, Salih, Weissberg, Murray, Littler olol increased the specificity of the exercise test, abolishing some false positive results, without reducing the sensitivity. No patient with coronary artery disease and a positive exercise test before treatment with fi blockers had a negative test when oxprenolol was introduced. However, two factors should be noted when these results are compared with ours. In the study by Marcomichelakis et al the patients performed symptom limited exercise tests and in these patients treatment with P blocker did delay the onset of ST depression.9 In the current study the patients performed submaximal exercise tests. Thus it is likely that the patients treated with I blockers had a higher incidence of false negative exercise tests than those who were not treated with 0 blockers. This is because f blockade abolished or delayed the onset of ST depression. This is consistent with the results of both Fox et al8 and Ho et al. "5 In these studies patients without a recent history of myocardial infarction performed maximal exercise tests on and off ( blockers. In both studies f blockade was associated with increased exercise duration and delay in onset of ST depression. In the study by Ho et al 14 patients with ST depression before I blockade developed equivocal tests while they were treated with f blockers. Fox et al found that 16 patients had complete and 16 had incomplete abolition of exercise induced ST depression when they were treated with f blockers. Thus it seems that on symptom limited exercise testing ,B blockade can abolish false positive exercise tests and reduce or delay the onset of ST depression in patients with multivessel disease. These data are consistent with our arteriographic data which showed a higher incidence of false negative tests in patients treated with f blockers (19%) than in those who were not (3%). It seems likely that f blockade prevented the development of ST depression on exercise in some of our patients.
The presence of ,B blockade at the time of exercise testing did not seem to limit the ability of the test to identify those patients who were at risk ofsubsequent cardiac events. When all cardiac events were grouped together, exercise testing was equally sensitive in identifying patients at risk of subsequent cardiac events in patients treated with fB blockers and those who were not. This also appeared to be true when cardiac events were studied individually. However, the number of events in each category is small and as a result the confidence intervals are wide. As far as we know the influence of, blockade on the prognostic implications ofpre-discharge exercise testing has not been evaluated before.
Why did P blockade seem to have a different effect on the ability of exercise testing to predict coronary anatomy than it did on the ability ofthe test to predict prognosis? This question is important because multivessel disease is recognised as one of the most useful predictors of prognosis after myocardial infarction. It may be that although multivessel disease does imply increased risk after infarction, it is still a non-specific marker."6 In the current study a large proportion of such patients had no subsequent cardiac event during the follow up period. This finding is consistent with the results of the Coronary Artery Surgery Study"8 and with the data of workers who studied the prognostic importance of multivessel disease after acute myocardial infarction.'"'8 It is well recognised that the patients with the worst prognosis after acute myocardial infarction are those with severe left ventricular dysfunction who are unable to perform a pre-discharge exercise test.46 Among patients with preserved left ventricular function who are able to perform an exercise test it seems likely that those with most severe ischaemia on exercise testing, in addition to those with multivessel disease, are also the group who are at greatest risk of subsequent cardiac events. Given that f blockade can delay or abolish myocardial ischaemia, as manifest by ST segment depression on exercise, it is also probable that exercise induced ST depression will be abolished in those with least severe ischaemia, even if they have multivessel disease. In contrast, if exercise induced ischaemia is so severe that it is not abolished by P blockade, it seems reasonable to expect that such a patient would have a high risk of subsequent cardiac events. Thus P blockade may in fact have filtered out patients with less severe ischaemia on exercise. It was to be expected, therefore, that while fB blockade might decrease the accuracy of submaximal exercise testing in identifying patients with multivessel disease it was less likely to reduce the ability of the test to identify patients at risk of subsequent cardiac events. This is bome out by the fact that none of the patients treated with f blockers who had negative exercise tests and multivessel disease died or reinfarcted.
CLINICAL IMPLICATIONS
These data have important implications for the assessment of patients after myocardial infarction. It seems that ( blockade reduces the ability of predischarge exercise testing to identify patients with multivessel disease. Despite this effect the test does not seem to lose its prognostic powers and is still able to identify patients at risk of subsequent cardiac events. Since this is the chief reason for performing the test we feel that it is not necessary to stop treatment with f blockers before pre-discharge exercise testing of patients who have had an acute myocardial infarction.
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